The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermal Filler and Botolinum Toxin Market Research Report 2024
Synopsis
This report studies the dermal filler and botolinum toxin market. Dermal filler and botolinum toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.
The global Dermal Filler and Botolinum Toxin market was valued at US$ 12050 million in 2023 and is anticipated to reach US$ 30390 million by 2030, witnessing a CAGR of 13.9% during the forecast period 2024-2030.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
This report aims to provide a comprehensive presentation of the global market for Dermal Filler and Botolinum Toxin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermal Filler and Botolinum Toxin.
Report Scope
The Dermal Filler and Botolinum Toxin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermal Filler and Botolinum Toxin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermal Filler and Botolinum Toxin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
Segment by Type
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Segment by Application
Aesthetic Restoration
Wrinkle Reduction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dermal Filler and Botolinum Toxin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dermal Filler and Botolinum Toxin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report studies the dermal filler and botolinum toxin market. Dermal filler and botolinum toxin can be used for the cosmetic treatment of facial lines, and the rejuvenation of skin and underlying tissues.
The global Dermal Filler and Botolinum Toxin market was valued at US$ 12050 million in 2023 and is anticipated to reach US$ 30390 million by 2030, witnessing a CAGR of 13.9% during the forecast period 2024-2030.
Demand in the dermal fillers and botulinum toxin market will continue to remain strong, offsetting any industry margincompression.Additionally, increasing research & development(R&D) initiatives to extend the therapeutic botulinumapplications of botulinum toxin and a rising number of cosmetic issues are some of the key drivers of the dermal fillers and botulinum toxin market. Botulinum toxin is a non-invasive cosmetic procedure, which is used to treat a wide variety of cosmetic issues, includingforehead creases and fine lines on the face. Due to its minimal pain and downtime, as well as its long-lasting effects,botulinum toxin treatments are becoming more popular among patients getting facelfts. As it has few side effects andcan be used several times a year for maximum outcomes, botulinum toxin has received particularly positivereviews. This factor would further boost the sale of botulinum toxin treatments in the forecast period.
This report aims to provide a comprehensive presentation of the global market for Dermal Filler and Botolinum Toxin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermal Filler and Botolinum Toxin.
Report Scope
The Dermal Filler and Botolinum Toxin market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermal Filler and Botolinum Toxin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermal Filler and Botolinum Toxin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Galderma
Merz Pharma GmbH & Co. KGaA
Anika Therapeutics
Suneva Medical
Contura
HUGEL
Grex Pharma
Daewoong Pharmaceuticals
Medy-Tox
TEOXANE Laboratories
SciVision Biotech
Segment by Type
Hyaluronic Acid Based Fillers
Non-Hyaluronic Acid Based Fillers
Botulinum Toxin
Segment by Application
Aesthetic Restoration
Wrinkle Reduction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dermal Filler and Botolinum Toxin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dermal Filler and Botolinum Toxin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dermal Filler and Botolinum Toxin Market Overview
1.1 Product Overview and Scope of Dermal Filler and Botolinum Toxin
1.2 Dermal Filler and Botolinum Toxin Segment by Type
1.2.1 Global Dermal Filler and Botolinum Toxin Market Value Comparison by Type (2024-2030)
1.2.2 Hyaluronic Acid Based Fillers
1.2.3 Non-Hyaluronic Acid Based Fillers
1.2.4 Botulinum Toxin
1.3 Dermal Filler and Botolinum Toxin Segment by Application
1.3.1 Global Dermal Filler and Botolinum Toxin Market Value by Application: (2024-2030)
1.3.2 Aesthetic Restoration
1.3.3 Wrinkle Reduction
1.4 Global Dermal Filler and Botolinum Toxin Market Size Estimates and Forecasts
1.4.1 Global Dermal Filler and Botolinum Toxin Revenue 2019-2030
1.4.2 Global Dermal Filler and Botolinum Toxin Sales 2019-2030
1.4.3 Global Dermal Filler and Botolinum Toxin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dermal Filler and Botolinum Toxin Market Competition by Manufacturers
2.1 Global Dermal Filler and Botolinum Toxin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dermal Filler and Botolinum Toxin Average Price by Manufacturers (2019-2024)
2.4 Global Dermal Filler and Botolinum Toxin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermal Filler and Botolinum Toxin, Product Type & Application
2.7 Dermal Filler and Botolinum Toxin Market Competitive Situation and Trends
2.7.1 Dermal Filler and Botolinum Toxin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dermal Filler and Botolinum Toxin Players Market Share by Revenue
2.7.3 Global Dermal Filler and Botolinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dermal Filler and Botolinum Toxin Retrospective Market Scenario by Region
3.1 Global Dermal Filler and Botolinum Toxin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dermal Filler and Botolinum Toxin Global Dermal Filler and Botolinum Toxin Sales by Region: 2019-2030
3.2.1 Global Dermal Filler and Botolinum Toxin Sales by Region: 2019-2024
3.2.2 Global Dermal Filler and Botolinum Toxin Sales by Region: 2025-2030
3.3 Global Dermal Filler and Botolinum Toxin Global Dermal Filler and Botolinum Toxin Revenue by Region: 2019-2030
3.3.1 Global Dermal Filler and Botolinum Toxin Revenue by Region: 2019-2024
3.3.2 Global Dermal Filler and Botolinum Toxin Revenue by Region: 2025-2030
3.4 North America Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.4.1 North America Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.4.3 North America Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.5.1 Europe Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.5.3 Europe Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.6.1 Asia Pacific Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.6.3 Asia Pacific Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.7.1 Latin America Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.7.3 Latin America Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermal Filler and Botolinum Toxin Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermal Filler and Botolinum Toxin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dermal Filler and Botolinum Toxin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dermal Filler and Botolinum Toxin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dermal Filler and Botolinum Toxin Sales by Type (2019-2030)
4.1.1 Global Dermal Filler and Botolinum Toxin Sales by Type (2019-2024)
4.1.2 Global Dermal Filler and Botolinum Toxin Sales by Type (2025-2030)
4.1.3 Global Dermal Filler and Botolinum Toxin Sales Market Share by Type (2019-2030)
4.2 Global Dermal Filler and Botolinum Toxin Revenue by Type (2019-2030)
4.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Type (2019-2024)
4.2.2 Global Dermal Filler and Botolinum Toxin Revenue by Type (2025-2030)
4.2.3 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Type (2019-2030)
4.3 Global Dermal Filler and Botolinum Toxin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dermal Filler and Botolinum Toxin Sales by Application (2019-2030)
5.1.1 Global Dermal Filler and Botolinum Toxin Sales by Application (2019-2024)
5.1.2 Global Dermal Filler and Botolinum Toxin Sales by Application (2025-2030)
5.1.3 Global Dermal Filler and Botolinum Toxin Sales Market Share by Application (2019-2030)
5.2 Global Dermal Filler and Botolinum Toxin Revenue by Application (2019-2030)
5.2.1 Global Dermal Filler and Botolinum Toxin Revenue by Application (2019-2024)
5.2.2 Global Dermal Filler and Botolinum Toxin Revenue by Application (2025-2030)
5.2.3 Global Dermal Filler and Botolinum Toxin Revenue Market Share by Application (2019-2030)
5.3 Global Dermal Filler and Botolinum Toxin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Dermal Filler and Botolinum Toxin Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Galderma
6.2.1 Galderma Corporation Information
6.2.2 Galderma Description and Business Overview
6.2.3 Galderma Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Galderma Dermal Filler and Botolinum Toxin Product Portfolio
6.2.5 Galderma Recent Developments/Updates
6.3 Merz Pharma GmbH & Co. KGaA
6.3.1 Merz Pharma GmbH & Co. KGaA Corporation Information
6.3.2 Merz Pharma GmbH & Co. KGaA Description and Business Overview
6.3.3 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merz Pharma GmbH & Co. KGaA Dermal Filler and Botolinum Toxin Product Portfolio
6.3.5 Merz Pharma GmbH & Co. KGaA Recent Developments/Updates
6.4 Anika Therapeutics
6.4.1 Anika Therapeutics Corporation Information
6.4.2 Anika Therapeutics Description and Business Overview
6.4.3 Anika Therapeutics Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Anika Therapeutics Dermal Filler and Botolinum Toxin Product Portfolio
6.4.5 Anika Therapeutics Recent Developments/Updates
6.5 Suneva Medical
6.5.1 Suneva Medical Corporation Information
6.5.2 Suneva Medical Description and Business Overview
6.5.3 Suneva Medical Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Suneva Medical Dermal Filler and Botolinum Toxin Product Portfolio
6.5.5 Suneva Medical Recent Developments/Updates
6.6 Contura
6.6.1 Contura Corporation Information
6.6.2 Contura Description and Business Overview
6.6.3 Contura Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Contura Dermal Filler and Botolinum Toxin Product Portfolio
6.6.5 Contura Recent Developments/Updates
6.7 HUGEL
6.6.1 HUGEL Corporation Information
6.6.2 HUGEL Description and Business Overview
6.6.3 HUGEL Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HUGEL Dermal Filler and Botolinum Toxin Product Portfolio
6.7.5 HUGEL Recent Developments/Updates
6.8 Grex Pharma
6.8.1 Grex Pharma Corporation Information
6.8.2 Grex Pharma Description and Business Overview
6.8.3 Grex Pharma Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Grex Pharma Dermal Filler and Botolinum Toxin Product Portfolio
6.8.5 Grex Pharma Recent Developments/Updates
6.9 Daewoong Pharmaceuticals
6.9.1 Daewoong Pharmaceuticals Corporation Information
6.9.2 Daewoong Pharmaceuticals Description and Business Overview
6.9.3 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Daewoong Pharmaceuticals Dermal Filler and Botolinum Toxin Product Portfolio
6.9.5 Daewoong Pharmaceuticals Recent Developments/Updates
6.10 Medy-Tox
6.10.1 Medy-Tox Corporation Information
6.10.2 Medy-Tox Description and Business Overview
6.10.3 Medy-Tox Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medy-Tox Dermal Filler and Botolinum Toxin Product Portfolio
6.10.5 Medy-Tox Recent Developments/Updates
6.11 TEOXANE Laboratories
6.11.1 TEOXANE Laboratories Corporation Information
6.11.2 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Description and Business Overview
6.11.3 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TEOXANE Laboratories Dermal Filler and Botolinum Toxin Product Portfolio
6.11.5 TEOXANE Laboratories Recent Developments/Updates
6.12 SciVision Biotech
6.12.1 SciVision Biotech Corporation Information
6.12.2 SciVision Biotech Dermal Filler and Botolinum Toxin Description and Business Overview
6.12.3 SciVision Biotech Dermal Filler and Botolinum Toxin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 SciVision Biotech Dermal Filler and Botolinum Toxin Product Portfolio
6.12.5 SciVision Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermal Filler and Botolinum Toxin Industry Chain Analysis
7.2 Dermal Filler and Botolinum Toxin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermal Filler and Botolinum Toxin Production Mode & Process
7.4 Dermal Filler and Botolinum Toxin Sales and Marketing
7.4.1 Dermal Filler and Botolinum Toxin Sales Channels
7.4.2 Dermal Filler and Botolinum Toxin Distributors
7.5 Dermal Filler and Botolinum Toxin Customers
8 Dermal Filler and Botolinum Toxin Market Dynamics
8.1 Dermal Filler and Botolinum Toxin Industry Trends
8.2 Dermal Filler and Botolinum Toxin Market Drivers
8.3 Dermal Filler and Botolinum Toxin Market Challenges
8.4 Dermal Filler and Botolinum Toxin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
